{"id":3160,"date":"2018-09-07T12:30:43","date_gmt":"2018-09-07T07:00:43","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=3160"},"modified":"2021-07-24T12:57:03","modified_gmt":"2021-07-24T07:27:03","slug":"now-nanoparticles-for-cancer-treatment","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment","title":{"rendered":"Now, Nanoparticles for Cancer Treatment"},"content":{"rendered":"<p>New areas of cancer treatment pop up every now and then without escaping our attention. And this time, it is\u2014getting drugs directly into cancer tumors using Nanoparticles.<\/p>\n<p>If the buzz doing the rounds in the industry circles is to be believed, then a new cancer therapy, which will use Nanoparticles to deliver combination therapies directly to cancer cells could be the next big thing in the cancer therapy arena. Nanoparticles are extremely small particles with 1 to 100 nanometer in diameter and are typically surrounded by interfacial layer.<\/p>\n<p>In a recent revelation by researchers from the East Anglia University in the UK, the Nanoparticle based cancer therapy, which have shown to make breast cancer and prostate cancer tumors more sensitive to chemotherapy, is close to entering clinical trials.<\/p>\n<p>The Nanoparticle based cancer therapy, in fact, is characterized by the usage of Nanoparticles to transport the combination of two separate drugs&#8211; the anti-cancer drug, Docetaxel, and Fingolimod, a multiple sclerosis drug that makes tumors more sensitive to chemotherapy\u2014directly to the cancer cells.<\/p>\n<p>Docetaxel and Fingolimod, if used singly, often entail risks that get reduced when used in combination, resulting into a potent therapy.<\/p>\n<p>Docetaxel, although is used to treat many cancers (breast, prostate, stomach, <a href=\"https:\/\/www.delveinsight.com\/report-store\/head-and-neck-cancer-hnc-market\">head, neck<\/a>), yet the resultant toxicity also can bring in serious side effects for the patients, whose tumors are chemo-resistant. While, Fingolimod suppresses the human immune system, when used directly, lowering the white blood cells in the administered patients. The risks get minimized to substantial levels when the drugs are directly transported to the tumors with the help of Nanoparticles. Also, as an associated advantage, less drugs will be required to kill the cancer cells as the drugs will directly be delivered at the tumor sites.<\/p>\n<p>Clinical trials for the Nanoparticle based cancer therapy were already carried out in mice that showed promising results, indicating its effectiveness in reducing breast and prostate tumors in humans.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>New areas of cancer treatment pop up every now and then without escaping our attention. And this time, it is\u2014getting drugs directly into cancer tumors using Nanoparticles. If the buzz doing the rounds in the industry circles is to be believed, then a new cancer therapy, which will use Nanoparticles to deliver combination therapies directly [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3161,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[41],"tags":[127,140,169,1764,1763,1766,1765,1762,498,1767],"industry":[17225],"therapeutic_areas":[17228],"class_list":["post-3160","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-snippets","tag-breast-cancer","tag-cancer-therapy","tag-clinical-trials","tag-docetaxel","tag-drug-insight","tag-east-anglia-university","tag-fingolimod","tag-nanoparticles","tag-prostate-cancer","tag-stomach-cancer","industry-pharmaceutical","therapeutic_areas-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Now, Nanoparticles for Cancer Treatment - DelveInsight Business Research<\/title>\n<meta name=\"description\" content=\"The Nanoparticle based cancer therapy, in fact, is characterized by the usage of Nanoparticles to transport the combination of two separate drugs......\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Now, Nanoparticles for Cancer Treatment - DelveInsight Business Research\" \/>\n<meta property=\"og:description\" content=\"The Nanoparticle based cancer therapy, in fact, is characterized by the usage of Nanoparticles to transport the combination of two separate drugs......\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-07T07:00:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-24T07:27:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/09\/09164122\/Nanoparticles-Kill-Cancer_hero.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"460\" \/>\n\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Now, Nanoparticles for Cancer Treatment - DelveInsight Business Research","description":"The Nanoparticle based cancer therapy, in fact, is characterized by the usage of Nanoparticles to transport the combination of two separate drugs......","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment","og_locale":"en_US","og_type":"article","og_title":"Now, Nanoparticles for Cancer Treatment - DelveInsight Business Research","og_description":"The Nanoparticle based cancer therapy, in fact, is characterized by the usage of Nanoparticles to transport the combination of two separate drugs......","og_url":"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2018-09-07T07:00:43+00:00","article_modified_time":"2021-07-24T07:27:03+00:00","og_image":[{"width":460,"height":360,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/09\/09164122\/Nanoparticles-Kill-Cancer_hero.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment","url":"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment","name":"Now, Nanoparticles for Cancer Treatment - DelveInsight Business Research","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/09\/09164122\/Nanoparticles-Kill-Cancer_hero.jpg","datePublished":"2018-09-07T07:00:43+00:00","dateModified":"2021-07-24T07:27:03+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"The Nanoparticle based cancer therapy, in fact, is characterized by the usage of Nanoparticles to transport the combination of two separate drugs......","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/now-nanoparticles-for-cancer-treatment#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/09\/09164122\/Nanoparticles-Kill-Cancer_hero.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/09\/09164122\/Nanoparticles-Kill-Cancer_hero.jpg","width":460,"height":360,"caption":"Nanoparticles"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/09\/09164122\/Nanoparticles-Kill-Cancer_hero-300x235.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Breast Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">cancer therapy<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Clinical trials<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Docetaxel<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">drug insight<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">East Anglia University<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Fingolimod<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Nanoparticles<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Prostate Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">stomach cancer<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Breast Cancer<\/span>","<span class=\"advgb-post-tax-term\">cancer therapy<\/span>","<span class=\"advgb-post-tax-term\">Clinical trials<\/span>","<span class=\"advgb-post-tax-term\">Docetaxel<\/span>","<span class=\"advgb-post-tax-term\">drug insight<\/span>","<span class=\"advgb-post-tax-term\">East Anglia University<\/span>","<span class=\"advgb-post-tax-term\">Fingolimod<\/span>","<span class=\"advgb-post-tax-term\">Nanoparticles<\/span>","<span class=\"advgb-post-tax-term\">Prostate Cancer<\/span>","<span class=\"advgb-post-tax-term\">stomach cancer<\/span>"]}},"comment_count":"1","relative_dates":{"created":"Posted 8 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Sep 7, 2018","modified":"Updated on Jul 24, 2021"},"absolute_dates_time":{"created":"Posted on Sep 7, 2018 12:30 pm","modified":"Updated on Jul 24, 2021 12:57 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/3160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=3160"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/3160\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/3161"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=3160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=3160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=3160"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=3160"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=3160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}